Gaudium IVF and Women Health LimitedGAUDIUMIVFCorporate

Medical Care Facilities Latest results: Jun 2026 6 quarters of data

₹101.46

MCap ₹738 Cr · P/E 34.2

Gaudium IVF and Women Health Limited — Stock analysis & AI research Gaudium IVF and Women Health Limited — Multibagger AI analysis Gaudium IVF and Women Health Limited — Seasonality — best & worst months Gaudium IVF and Women Health Limited — Technical setup — score, trend, support & resistance Gaudium IVF and Women Health Limited — Live exchange announcements

📋 High Operating Margin Stocks 📋 High Interest Coverage Stocks 📈 Lowest Technical Score 🏭 Healthcare sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹14 Cr

Sales · Jun 2026

+11.5% YoY

₹2 Cr

Operating Profit · Jun 2026

-47.7% YoY

15.9%

OPM % · Jun 2026

-53.1% YoY

₹2 Cr

Net Profit · Jun 2026

-29.2% YoY

₹0.23

EPS · Jun 2026

-39.5% YoY

📝 Gaudium IVF and Women Health Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Gaudium IVF and Women Health Limited reported revenue of ₹14 crore for the quarter ended June 2026 (Q1 FY27), up 11.5% from ₹12 crore in the same quarter last year, and down 38.3% sequentially over the March 2026 quarter.

Net profit fell 29.2% year-on-year to ₹2 crore, from ₹2 crore. Earnings per share (EPS) came in at ₹0.23.

Operating profit stood at ₹2 crore — an operating margin (OPM) of 15.9%, compared with 33.9% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Gaudium IVF and Women Health Limited posted revenue of ₹72 crore, with a net profit of ₹22 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹73 crore with a net profit of ₹22 crore.

Valuation snapshot

At the current price of ₹101.46, GAUDIUMIVF has a market capitalisation of ₹738 crore and a trailing P/E of about 34.2.

Within the Medical Care Facilities industry, it is the 10th-largest of the 11 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 71.29%, foreign institutional investors (FIIs) 1.19%, domestic institutional investors (DIIs) 2.22%, public shareholders 25.29% of Gaudium IVF and Women Health Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹738 Cr

Current Price ?

₹101.5

P/E ?

34.18below ind

Industry P/E ?

56.40

P/B ?

N/A

P/S ?

10.12

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

2.9%

Dividend Yield ?

N/A

Profitability & Returns

Sales (TTM) ?

₹73 Cr

OPM ?

44.6%

Profit after tax (TTM) ?

₹22 Cr

EPS (TTM) ?

₹2.97

ROCE ?

N/A

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹14 Cr

PAT — latest qtr ?

₹2 Cr

YoY qtr sales growth ?

11.5%

YoY qtr profit growth ?

-29.2%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

N/A

Debt to Equity ?

N/A

Interest Coverage ?

9.6

Current Ratio ?

N/A

Ownership

Promoter holding ?

71.29%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

-29.4%

Return 6 months ?

4.7%

🗓️ Quarterly results (6 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	17	12	23	14	22	14	+11.5%	-38.3%
Operating Profit	8	4	13	6	11	2	-47.7%	-80.7%
Other Income	0	0	0	0	0	1	—	+524.2%
Interest	0	0	1	1	1	0	-35.5%	-74.0%
Depreciation	0	1	1	0	1	1	+16.4%	+10.7%
Profit Before Tax	8	3	12	4	10	2	-25.3%	-76.0%
Net Profit	6	2	9	3	8	2	-29.2%	-78.5%
EPS	1.01	0.38	1.47	0.52	1.06	0.23	-39.5%	-78.3%
OPM %	49.2%	33.9%	57.9%	41.1%	50.8%	15.9%	-53.1%	-68.7%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	Prev FY	FY26	TTM	YoY %
Sales	—	₹72 Cr	₹73 Cr	—
Operating Profit	—	₹35 Cr	₹33 Cr	—
OPM %	—	48.24%	44.59%	—
NPM %	—	31.14%	29.60%	—
Other Income	—	₹0 Cr	₹2 Cr	—
Depreciation	—	₹2 Cr	₹2 Cr	—
Interest	—	₹3 Cr	₹3 Cr	—
EBIT	—	₹32 Cr	₹30 Cr	—
PBT	—	₹29 Cr	₹29 Cr	—
Tax	—	₹1 Cr	₹2 Cr	—
Net Profit	—	₹22 Cr	₹22 Cr	—
EPS	—	₹3.43	₹3.28	—
Material Cost	—	₹4 Cr	₹6 Cr	—
Employee Cost	—	₹2 Cr	₹4 Cr	—
Extraordinary Items	—	—	—	—

👥 Shareholding (latest 1 periods)

Metric	Sep 2026	% Chg
Promoters	71.29%	—
FIIs	1.19%	—
DIIs	2.22%	—
Public	25.29%	—
No. of Shareholders	24,051	—

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	APOLLOHOSP Apollo Hospitals	₹7,988.50	114,862	59.2	25,229	2,002	14.9%	7.9%	15.8%	33.1%	18.1%	32.9%
2	MAXHEALTH Max Healthcare	₹1,037.70	101,000	69.2	8,712	1,457	26.6%	16.7%	19.1%	34.1%	16.7%	4.9%
3	MANIPALHOS Manipal Health	₹710.85	93,504	—	—	—	—	—	—	—	28.2%	-8.3%
4	FORTIS Fortis Healthcare	₹887.80	67,025	64.3	9,128	1,064	22.8%	11.7%	17.3%	31.4%	17.8%	44.1%
5	ASTERDM Aster DM	₹763.50	66,552	198.5	4,876	363	19.0%	7.5%	44.2%	138.8%	21.6%	-68.9%
6	MEDANTA Global Health	₹1,445.60	38,846	69.8	4,683	553	20.9%	11.8%	19.4%	15.1%	26.5%	-1.1%
7	NH Narayana Hrudayalaya	₹1,869.90	37,978	46.6	9,073	817	19.3%	9.0%	41.4%	1.9%	78.0%	5.4%
8	KIMS Krishna Institute	₹767.50	30,711	148.9	4,214	194	19.8%	4.6%	28.7%	-41.5%	35.3%	-56.0%
9	RAINBOW Rainbow Children's	₹1,450.00	14,710	51.6	1,820	290	31.6%	15.9%	12.4%	15.2%	33.2%	16.2%
10	GAUDIUMIVF Gaudium IVF	₹116.42	847	36.4	106	23	32.9%	21.8%	—	—	9.1%	-42.2%
11	MOMSBELIEF Rays of Belief	₹223.00	466	—	—	—	—	—	—	—	136.4%	616.1%

❓ Frequently asked questions

What was Gaudium IVF and Women Health Limited's revenue in Q1 FY27?

What was Gaudium IVF and Women Health Limited's net profit in Q1 FY27?

Net profit fell 29.2% year-on-year to ₹2 crore, from ₹2 crore. Earnings per share (EPS) came in at ₹0.23.

What is GAUDIUMIVF's market capitalisation and P/E ratio?

At the current price of ₹101.46, GAUDIUMIVF has a market capitalisation of ₹738 crore and a trailing P/E of about 34.2.

Who owns Gaudium IVF and Women Health Limited? (shareholding pattern)

As of Sep 2026, promoters held 71.29%, foreign institutional investors (FIIs) 1.19%, domestic institutional investors (DIIs) 2.22%, public shareholders 25.29% of Gaudium IVF and Women Health Limited.

TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.

Gaudium IVF and Women Health LimitedGAUDIUMIVFCorporate

📝 Gaudium IVF and Women Health Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Full year and trailing twelve months

Valuation snapshot

Shareholding pattern

📈 Share price & events

📊 Quarterly trend

🎯 Key metrics

🗓️ Quarterly results (6 quarters · ₹ Cr)

📆 Annual results (₹ Cr, FY = Apr–Mar)

👥 Shareholding (latest 1 periods)

⚖️ Peer comparison

⚡ Free FlashFinance Newsletters

You're subscribed!

Get daily updates?